The Cost‐Effectiveness of Interleukin‐1 Genetic Testing for Periodontal Disease
Authors:
- David L. VeenstraDVDavid L. Veenstra
- Michael Del AguilaMAMichael Del Aguila
- Philippe HujoelPHPhilippe Hujoel
- 1 December 2002
- journal article
- Published by Wiley in Journal of Periodontology
- Vol. 73 (12) , 1474-1484
Abstract
Background: A genetic test for a composite interleukin‐1 (IL‐1) genotype is being marketed to predict risk for progression of periodontal disease. The objective of this study was to determine the clinical scenario required to produce cost‐effective results with the use of IL‐1 testing to identify high‐risk patients.Methods: A disease simulation model was developed using decision‐analytic techniques and a 30‐year time frame.Results: Using different modeling scenarios, the genetic test produced results ranging from cost savings of $830,140 and 52.8 fewer cases of severe periodontitis to increased costs of $300,430 and 3.6 additional cases of severe periodontitis (per 1,000 patients). Three parameters in the analysis were highly influential: 1) the compliance rate for maintenance therapy in test positive versus non‐tested patients; 2) the effectiveness of non‐surgical therapy; and 3) the relative risk of disease progression for test positive patients.Conclusion: The model produced a wide range of outcomes reflecting our incomplete understanding of the biology, optimal treatment, and genetic susceptibility of periodontal diseases. However, the model demonstrates that three clinical parameters are highly influential in determining if IL‐1 testing can be implemented in a primary care setting in a cost‐effective manner. J Periodontol 2002;73:1474‐1484.Keywords
This publication has 38 references indexed in Scilit:
- Expression and Immunogenicity of Hemagglutinin A from Porphyromonas gingivalis in an Avirulent Salmonella enterica Serovar Typhimurium Vaccine StrainInfection and Immunity, 2000
- Quitting chew: Results from a randomized trial using nicotine patches.Experimental and Clinical Psychopharmacology, 1999
- Transdermal Nicotine Therapy and Primary Care: Importance of Counseling, Demographic, and Participant Selection Factors on 1-Year Quit RatesArchives of Family Medicine, 1998
- An Introduction to Markov Modelling for Economic EvaluationPharmacoEconomics, 1998
- Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counselingArchives of internal medicine (1960), 1993
- Patient attendance compliance in periodontal therapyAustralian Dental Journal, 1992
- Compliance With Supportive Periodontal TherapyJournal of Periodontology, 1991
- Evaluation of Furcation Region Response to Periodontal TherapyJournal of Periodontology, 1988
- Compliance with Maintenance Therapy in a Private Periodontal PracticeJournal of Periodontology, 1984
- A Long‐Term Survey of Tooth Loss in 600 Treated Periodontal PatientsJournal of Periodontology, 1978